Sign in
CompletedNo phase

The Application of Different Sedation Protocols in ICU Patients With Severe Pneumonia

Key facts

Who runs it
Xiangya Hospital of Central South University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
260 people enrolled
Started
1 Feb 2023
Ended
27 Jan 2025
Type of study
Observational, 2 groups
Record updated
21 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • (1)From February 1, 2023, to December 31, 2024, diagnosed with severe pneumonia in the Respiratory Intensive Care Unit of Xiangya Hospital, Central South University. The diagnosis of severe pneumonia is based on meeting at least one major criterion or three or more minor criteria:
  • Major criteria:; ①Infectious shock requiring vasopressor therapy despite adequate fluid resuscitation; ②Respiratory failure requiring tracheal intubation or mechanical ventilation
  • Minor criteria:; Respiratory rate ≥ 30 breaths/min; Oxygenation index (PaO2/FiO2) ≤ 250; ③Involvement of multiple lobes; Altered mental status and/or disorientation; ⑤Blood urea nitrogen ≥ 20 mg/dl (7.14 mmol/L); ⑥Systolic blood pressure < 90 mmHg requiring aggressive fluid resuscitation. (2)Patients receiving invasive mechanical ventilation who require continuous sedation treatment; (3)Age ≥ 18 years

Who cannot take part

  • Allergic to routine sedative or analgesic medications
  • Patients who have not undergone sedation-agitation assessment
  • Patients transferred to another hospital during treatment
  • Patients who withdrew from active treatment or were discharged from the ICU within 72 hours after initiation of sedation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study collected data from patients with severe pneumonia to compare the duration of mechanical ventilation under different sedation regimens in real-world settings. It also evaluated and compared the sedation success rates, hemodynamic changes, and clinical outcomes of patients with severe pneumonia.

The 2 groups in the trial

  • Cipepofol group

    Initially use cipepofol as the sedative medication, with a continuous usage duration of more than 48 hours.

  • Conventional group

    Initially use non-cipepofol sedative medications, with a continuous usage duration of more than 48 hours.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
21 September 2026